Cargando…

SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ying, Skarlupka, Amanda L., Jang, Hyesun, Blas-Machado, Uriel, Holladay, Nathan, Hogan, R. Jeffrey, Ross, Ted M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906421/
https://www.ncbi.nlm.nih.gov/pubmed/34936487
http://dx.doi.org/10.1128/jvi.01791-21
_version_ 1784665400477220864
author Huang, Ying
Skarlupka, Amanda L.
Jang, Hyesun
Blas-Machado, Uriel
Holladay, Nathan
Hogan, R. Jeffrey
Ross, Ted M.
author_facet Huang, Ying
Skarlupka, Amanda L.
Jang, Hyesun
Blas-Machado, Uriel
Holladay, Nathan
Hogan, R. Jeffrey
Ross, Ted M.
author_sort Huang, Ying
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic. IMPORTANCE Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report.
format Online
Article
Text
id pubmed-8906421
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-89064212022-03-10 SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets Huang, Ying Skarlupka, Amanda L. Jang, Hyesun Blas-Machado, Uriel Holladay, Nathan Hogan, R. Jeffrey Ross, Ted M. J Virol Vaccines and Antiviral Agents Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic. IMPORTANCE Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report. American Society for Microbiology 2022-03-09 /pmc/articles/PMC8906421/ /pubmed/34936487 http://dx.doi.org/10.1128/jvi.01791-21 Text en Copyright © 2022 American Society for Microbiology. https://doi.org/10.1128/ASMCopyrightv2All Rights Reserved (https://doi.org/10.1128/ASMCopyrightv2) . https://doi.org/10.1128/ASMCopyrightv2This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Vaccines and Antiviral Agents
Huang, Ying
Skarlupka, Amanda L.
Jang, Hyesun
Blas-Machado, Uriel
Holladay, Nathan
Hogan, R. Jeffrey
Ross, Ted M.
SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
title SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
title_full SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
title_fullStr SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
title_full_unstemmed SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
title_short SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
title_sort sars-cov-2 and influenza a virus coinfections in ferrets
topic Vaccines and Antiviral Agents
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906421/
https://www.ncbi.nlm.nih.gov/pubmed/34936487
http://dx.doi.org/10.1128/jvi.01791-21
work_keys_str_mv AT huangying sarscov2andinfluenzaaviruscoinfectionsinferrets
AT skarlupkaamandal sarscov2andinfluenzaaviruscoinfectionsinferrets
AT janghyesun sarscov2andinfluenzaaviruscoinfectionsinferrets
AT blasmachadouriel sarscov2andinfluenzaaviruscoinfectionsinferrets
AT holladaynathan sarscov2andinfluenzaaviruscoinfectionsinferrets
AT hoganrjeffrey sarscov2andinfluenzaaviruscoinfectionsinferrets
AT rosstedm sarscov2andinfluenzaaviruscoinfectionsinferrets